Tristel PLC
Tristel PLC (TSNLF) Stock Competitors & Peer Comparison
See (TSNLF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TSNLF | $5.29 | +0.00% | 252.4M | 33.06 | $0.16 | +3.44% |
| SRTOY | $19.62 | -4.39% | 190.8B | 75.44 | $0.26 | +0.39% |
| ESLOF | $296.07 | -0.92% | 136.5B | 49.51 | $5.98 | +1.50% |
| ESLOY | $147.15 | -0.82% | 135.7B | 49.38 | $2.98 | +1.53% |
| MECNY | $88.63 | +0.00% | 107.8B | N/A | N/A | N/A |
| SOAGY | $41.58 | -0.12% | 64.2B | 121.13 | $0.34 | +0.21% |
| HOCPF | $126.44 | +6.24% | 43.3B | 32.34 | $3.91 | +0.86% |
| HOCPY | $123.98 | +0.16% | 42.5B | 31.87 | $3.89 | +0.41% |
| RSMDF | $24.77 | +0.00% | 40.9B | 26.07 | $0.95 | +0.75% |
| TRUMF | $17.90 | +2.37% | 26.4B | 33.15 | $0.54 | +0.99% |
Stock Comparison
TSNLF vs SRTOY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SRTOY has a market cap of 190.8B. Regarding current trading prices, TSNLF is priced at $5.29, while SRTOY trades at $19.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SRTOY's P/E ratio is 75.44. In terms of profitability, TSNLF's ROE is +0.21%, compared to SRTOY's ROE of +0.06%. Regarding short-term risk, TSNLF is more volatile compared to SRTOY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SRTOY's competition here
TSNLF vs ESLOF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ESLOF has a market cap of 136.5B. Regarding current trading prices, TSNLF is priced at $5.29, while ESLOF trades at $296.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ESLOF's P/E ratio is 49.51. In terms of profitability, TSNLF's ROE is +0.21%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, TSNLF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check ESLOF's competition here
TSNLF vs ESLOY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ESLOY has a market cap of 135.7B. Regarding current trading prices, TSNLF is priced at $5.29, while ESLOY trades at $147.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ESLOY's P/E ratio is 49.38. In terms of profitability, TSNLF's ROE is +0.21%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, TSNLF is more volatile compared to ESLOY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check ESLOY's competition here
TSNLF vs MECNY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, MECNY has a market cap of 107.8B. Regarding current trading prices, TSNLF is priced at $5.29, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas MECNY's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to MECNY's ROE of +0.07%. Regarding short-term risk, TSNLF is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check MECNY's competition here
TSNLF vs SOAGY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SOAGY has a market cap of 64.2B. Regarding current trading prices, TSNLF is priced at $5.29, while SOAGY trades at $41.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SOAGY's P/E ratio is 121.13. In terms of profitability, TSNLF's ROE is +0.21%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, TSNLF is more volatile compared to SOAGY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SOAGY's competition here
TSNLF vs HOCPF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, HOCPF has a market cap of 43.3B. Regarding current trading prices, TSNLF is priced at $5.29, while HOCPF trades at $126.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas HOCPF's P/E ratio is 32.34. In terms of profitability, TSNLF's ROE is +0.21%, compared to HOCPF's ROE of +0.21%. Regarding short-term risk, TSNLF is more volatile compared to HOCPF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check HOCPF's competition here
TSNLF vs HOCPY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, HOCPY has a market cap of 42.5B. Regarding current trading prices, TSNLF is priced at $5.29, while HOCPY trades at $123.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas HOCPY's P/E ratio is 31.87. In terms of profitability, TSNLF's ROE is +0.21%, compared to HOCPY's ROE of +0.20%. Regarding short-term risk, TSNLF is more volatile compared to HOCPY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check HOCPY's competition here
TSNLF vs RSMDF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, RSMDF has a market cap of 40.9B. Regarding current trading prices, TSNLF is priced at $5.29, while RSMDF trades at $24.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas RSMDF's P/E ratio is 26.07. In terms of profitability, TSNLF's ROE is +0.21%, compared to RSMDF's ROE of +0.26%. Regarding short-term risk, TSNLF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check RSMDF's competition here
TSNLF vs TRUMF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TRUMF has a market cap of 26.4B. Regarding current trading prices, TSNLF is priced at $5.29, while TRUMF trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TRUMF's P/E ratio is 33.15. In terms of profitability, TSNLF's ROE is +0.21%, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, TSNLF is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check TRUMF's competition here
TSNLF vs TRUMY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TRUMY has a market cap of 25.4B. Regarding current trading prices, TSNLF is priced at $5.29, while TRUMY trades at $17.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TRUMY's P/E ratio is 31.93. In terms of profitability, TSNLF's ROE is +0.21%, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, TSNLF is more volatile compared to TRUMY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check TRUMY's competition here
TSNLF vs CLPBY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CLPBY has a market cap of 21B. Regarding current trading prices, TSNLF is priced at $5.29, while CLPBY trades at $9.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CLPBY's P/E ratio is 30.35. In terms of profitability, TSNLF's ROE is +0.21%, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, TSNLF is more volatile compared to CLPBY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check CLPBY's competition here
TSNLF vs CLPBF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CLPBF has a market cap of 20.8B. Regarding current trading prices, TSNLF is priced at $5.29, while CLPBF trades at $92.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CLPBF's P/E ratio is 29.96. In terms of profitability, TSNLF's ROE is +0.21%, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, TSNLF is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check CLPBF's competition here
TSNLF vs SAUHY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SAUHY has a market cap of 20.2B. Regarding current trading prices, TSNLF is priced at $5.29, while SAUHY trades at $12.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SAUHY's P/E ratio is 35.17. In terms of profitability, TSNLF's ROE is +0.21%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, TSNLF is more volatile compared to SAUHY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SAUHY's competition here
TSNLF vs SAUHF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SAUHF has a market cap of 20B. Regarding current trading prices, TSNLF is priced at $5.29, while SAUHF trades at $125.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SAUHF's P/E ratio is 33.83. In terms of profitability, TSNLF's ROE is +0.21%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, TSNLF is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check SAUHF's competition here
TSNLF vs SDMHF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SDMHF has a market cap of 18.6B. Regarding current trading prices, TSNLF is priced at $5.29, while SDMHF trades at $191.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SDMHF's P/E ratio is 72.17. In terms of profitability, TSNLF's ROE is +0.21%, compared to SDMHF's ROE of +0.06%. Regarding short-term risk, TSNLF is more volatile compared to SDMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SDMHF's competition here
TSNLF vs SARTF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SARTF has a market cap of 14B. Regarding current trading prices, TSNLF is priced at $5.29, while SARTF trades at $184.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SARTF's P/E ratio is 106.51. In terms of profitability, TSNLF's ROE is +0.21%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, TSNLF is less volatile compared to SARTF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check SARTF's competition here
TSNLF vs OCPNF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, OCPNF has a market cap of 13.6B. Regarding current trading prices, TSNLF is priced at $5.29, while OCPNF trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas OCPNF's P/E ratio is 17.29. In terms of profitability, TSNLF's ROE is +0.21%, compared to OCPNF's ROE of +0.16%. Regarding short-term risk, TSNLF is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check OCPNF's competition here
TSNLF vs SUVPF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SUVPF has a market cap of 13.1B. Regarding current trading prices, TSNLF is priced at $5.29, while SUVPF trades at $210.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SUVPF's P/E ratio is 120.16. In terms of profitability, TSNLF's ROE is +0.21%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, TSNLF is more volatile compared to SUVPF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SUVPF's competition here
TSNLF vs SSSGY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SSSGY has a market cap of 13.1B. Regarding current trading prices, TSNLF is priced at $5.29, while SSSGY trades at $42.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SSSGY's P/E ratio is 125.03. In terms of profitability, TSNLF's ROE is +0.21%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, TSNLF is more volatile compared to SSSGY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SSSGY's competition here
TSNLF vs FSPKF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, FSPKF has a market cap of 11.7B. Regarding current trading prices, TSNLF is priced at $5.29, while FSPKF trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas FSPKF's P/E ratio is 52.66. In terms of profitability, TSNLF's ROE is +0.21%, compared to FSPKF's ROE of +0.28%. Regarding short-term risk, TSNLF is less volatile compared to FSPKF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check FSPKF's competition here
TSNLF vs SSMXY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SSMXY has a market cap of 10.4B. Regarding current trading prices, TSNLF is priced at $5.29, while SSMXY trades at $16.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SSMXY's P/E ratio is 28.78. In terms of profitability, TSNLF's ROE is +0.21%, compared to SSMXY's ROE of +0.12%. Regarding short-term risk, TSNLF is more volatile compared to SSMXY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SSMXY's competition here
TSNLF vs SSMXF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SSMXF has a market cap of 9.5B. Regarding current trading prices, TSNLF is priced at $5.29, while SSMXF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SSMXF's P/E ratio is 26.38. In terms of profitability, TSNLF's ROE is +0.21%, compared to SSMXF's ROE of +0.12%. Regarding short-term risk, TSNLF is more volatile compared to SSMXF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SSMXF's competition here
TSNLF vs YPHDF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, YPHDF has a market cap of 7.3B. Regarding current trading prices, TSNLF is priced at $5.29, while YPHDF trades at $535.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas YPHDF's P/E ratio is 67.99. In terms of profitability, TSNLF's ROE is +0.21%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, TSNLF is more volatile compared to YPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check YPHDF's competition here
TSNLF vs CNVVF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CNVVF has a market cap of 7.1B. Regarding current trading prices, TSNLF is priced at $5.29, while CNVVF trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CNVVF's P/E ratio is 31.61. In terms of profitability, TSNLF's ROE is +0.21%, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, TSNLF is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check CNVVF's competition here
TSNLF vs CNVVY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CNVVY has a market cap of 6.4B. Regarding current trading prices, TSNLF is priced at $5.29, while CNVVY trades at $12.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CNVVY's P/E ratio is 29.64. In terms of profitability, TSNLF's ROE is +0.21%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, TSNLF is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check CNVVY's competition here
TSNLF vs FLMNY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, FLMNY has a market cap of 5.4B. Regarding current trading prices, TSNLF is priced at $5.29, while FLMNY trades at $12.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas FLMNY's P/E ratio is 29.23. In terms of profitability, TSNLF's ROE is +0.21%, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, TSNLF is more volatile compared to FLMNY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check FLMNY's competition here
TSNLF vs FLMNF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, FLMNF has a market cap of 5.2B. Regarding current trading prices, TSNLF is priced at $5.29, while FLMNF trades at $61.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas FLMNF's P/E ratio is 27.86. In terms of profitability, TSNLF's ROE is +0.21%, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, TSNLF is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check FLMNF's competition here
TSNLF vs ADDLF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, TSNLF is priced at $5.29, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, TSNLF's ROE is +0.21%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, TSNLF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check ADDLF's competition here
TSNLF vs CZMWY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CZMWY has a market cap of 4.9B. Regarding current trading prices, TSNLF is priced at $5.29, while CZMWY trades at $55.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CZMWY's P/E ratio is 27.53. In terms of profitability, TSNLF's ROE is +0.21%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, TSNLF is more volatile compared to CZMWY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check CZMWY's competition here
TSNLF vs CZMWF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CZMWF has a market cap of 4.7B. Regarding current trading prices, TSNLF is priced at $5.29, while CZMWF trades at $53.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CZMWF's P/E ratio is 26.23. In terms of profitability, TSNLF's ROE is +0.21%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, TSNLF is more volatile compared to CZMWF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check CZMWF's competition here
TSNLF vs AHICF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, AHICF has a market cap of 4.4B. Regarding current trading prices, TSNLF is priced at $5.29, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas AHICF's P/E ratio is 59.89. In terms of profitability, TSNLF's ROE is +0.21%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, TSNLF is more volatile compared to AHICF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check AHICF's competition here
TSNLF vs SHWGF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SHWGF has a market cap of 3.4B. Regarding current trading prices, TSNLF is priced at $5.29, while SHWGF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SHWGF's P/E ratio is 12.67. In terms of profitability, TSNLF's ROE is +0.21%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, TSNLF is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check SHWGF's competition here
TSNLF vs ANSLY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ANSLY has a market cap of 2.9B. Regarding current trading prices, TSNLF is priced at $5.29, while ANSLY trades at $79.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ANSLY's P/E ratio is 24.23. In terms of profitability, TSNLF's ROE is +0.21%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, TSNLF is more volatile compared to ANSLY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check ANSLY's competition here
TSNLF vs TCHBF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TCHBF has a market cap of 2.7B. Regarding current trading prices, TSNLF is priced at $5.29, while TCHBF trades at $211.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TCHBF's P/E ratio is 32.55. In terms of profitability, TSNLF's ROE is +0.21%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, TSNLF is less volatile compared to TCHBF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check TCHBF's competition here
TSNLF vs ANSLF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ANSLF has a market cap of 2.6B. Regarding current trading prices, TSNLF is priced at $5.29, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, TSNLF's ROE is +0.21%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, TSNLF is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check ANSLF's competition here
TSNLF vs TCGGY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, TSNLF is priced at $5.29, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TCGGY's P/E ratio is 27.27. In terms of profitability, TSNLF's ROE is +0.21%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, TSNLF is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check TCGGY's competition here
TSNLF vs BOEUF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, BOEUF has a market cap of 2.2B. Regarding current trading prices, TSNLF is priced at $5.29, while BOEUF trades at $34.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas BOEUF's P/E ratio is 148.26. In terms of profitability, TSNLF's ROE is +0.21%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, TSNLF is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check BOEUF's competition here
TSNLF vs EKTAY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, EKTAY has a market cap of 1.8B. Regarding current trading prices, TSNLF is priced at $5.29, while EKTAY trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas EKTAY's P/E ratio is 79.92. In terms of profitability, TSNLF's ROE is +0.21%, compared to EKTAY's ROE of +0.02%. Regarding short-term risk, TSNLF is more volatile compared to EKTAY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check EKTAY's competition here
TSNLF vs EKTAF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, EKTAF has a market cap of 1.8B. Regarding current trading prices, TSNLF is priced at $5.29, while EKTAF trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas EKTAF's P/E ratio is 82.67. In terms of profitability, TSNLF's ROE is +0.21%, compared to EKTAF's ROE of +0.02%. Regarding short-term risk, TSNLF is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check EKTAF's competition here
TSNLF vs GRRMF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, GRRMF has a market cap of 1.8B. Regarding current trading prices, TSNLF is priced at $5.29, while GRRMF trades at $51.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas GRRMF's P/E ratio is 24.60. In terms of profitability, TSNLF's ROE is +0.21%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, TSNLF is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check GRRMF's competition here
TSNLF vs NPRRF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, NPRRF has a market cap of 1.5B. Regarding current trading prices, TSNLF is priced at $5.29, while NPRRF trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas NPRRF's P/E ratio is 43.32. In terms of profitability, TSNLF's ROE is +0.21%, compared to NPRRF's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to NPRRF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check NPRRF's competition here
TSNLF vs TDVXF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TDVXF has a market cap of 1.4B. Regarding current trading prices, TSNLF is priced at $5.29, while TDVXF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TDVXF's P/E ratio is 88.33. In terms of profitability, TSNLF's ROE is +0.21%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, TSNLF is more volatile compared to TDVXF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check TDVXF's competition here
TSNLF vs TGLVY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TGLVY has a market cap of 1.3B. Regarding current trading prices, TSNLF is priced at $5.29, while TGLVY trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TGLVY's P/E ratio is 64.32. In terms of profitability, TSNLF's ROE is +0.21%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, TSNLF is more volatile compared to TGLVY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check TGLVY's competition here
TSNLF vs BITGF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, TSNLF is priced at $5.29, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas BITGF's P/E ratio is 45.50. In terms of profitability, TSNLF's ROE is +0.21%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, TSNLF is more volatile compared to BITGF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check BITGF's competition here
TSNLF vs PBHDF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, PBHDF has a market cap of 1.1B. Regarding current trading prices, TSNLF is priced at $5.29, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, TSNLF's ROE is +0.21%, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, TSNLF is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check PBHDF's competition here
TSNLF vs SHWGY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SHWGY has a market cap of 980.8M. Regarding current trading prices, TSNLF is priced at $5.29, while SHWGY trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SHWGY's P/E ratio is 13.88. In terms of profitability, TSNLF's ROE is +0.21%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, TSNLF is more volatile compared to SHWGY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SHWGY's competition here
TSNLF vs NNCSF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, NNCSF has a market cap of 743.9M. Regarding current trading prices, TSNLF is priced at $5.29, while NNCSF trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas NNCSF's P/E ratio is 81.67. In terms of profitability, TSNLF's ROE is +0.21%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, TSNLF is less volatile compared to NNCSF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check NNCSF's competition here
TSNLF vs KSRBF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, KSRBF has a market cap of 686.6M. Regarding current trading prices, TSNLF is priced at $5.29, while KSRBF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas KSRBF's P/E ratio is 3.86. In terms of profitability, TSNLF's ROE is +0.21%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, TSNLF is more volatile compared to KSRBF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check KSRBF's competition here
TSNLF vs SAFLY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SAFLY has a market cap of 585.4M. Regarding current trading prices, TSNLF is priced at $5.29, while SAFLY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SAFLY's P/E ratio is 19.08. In terms of profitability, TSNLF's ROE is +0.21%, compared to SAFLY's ROE of +0.05%. Regarding short-term risk, TSNLF is more volatile compared to SAFLY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SAFLY's competition here
TSNLF vs JNDOF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, TSNLF is priced at $5.29, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, TSNLF's ROE is +0.21%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, TSNLF is more volatile compared to JNDOF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check JNDOF's competition here
TSNLF vs HGYMF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, HGYMF has a market cap of 524.8M. Regarding current trading prices, TSNLF is priced at $5.29, while HGYMF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas HGYMF's P/E ratio is 33.81. In terms of profitability, TSNLF's ROE is +0.21%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, TSNLF is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check HGYMF's competition here
TSNLF vs SAFLF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SAFLF has a market cap of 520.2M. Regarding current trading prices, TSNLF is priced at $5.29, while SAFLF trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SAFLF's P/E ratio is 21.50. In terms of profitability, TSNLF's ROE is +0.21%, compared to SAFLF's ROE of +0.05%. Regarding short-term risk, TSNLF is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check SAFLF's competition here
TSNLF vs SPMXF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, TSNLF is priced at $5.29, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, TSNLF's ROE is +0.21%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, TSNLF is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check SPMXF's competition here
TSNLF vs CLHLF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, TSNLF is priced at $5.29, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, TSNLF's ROE is +0.21%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, TSNLF is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check CLHLF's competition here
TSNLF vs GUERF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, TSNLF is priced at $5.29, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas GUERF's P/E ratio is 8.19. In terms of profitability, TSNLF's ROE is +0.21%, compared to GUERF's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check GUERF's competition here
TSNLF vs OPSSF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, TSNLF is priced at $5.29, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, TSNLF's ROE is +0.21%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, TSNLF is more volatile compared to OPSSF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check OPSSF's competition here
TSNLF vs EEOIF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, TSNLF is priced at $5.29, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, TSNLF's ROE is +0.21%, compared to EEOIF's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check EEOIF's competition here
TSNLF vs UEEC Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, UEEC has a market cap of 18.5M. Regarding current trading prices, TSNLF is priced at $5.29, while UEEC trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas UEEC's P/E ratio is -7.21. In terms of profitability, TSNLF's ROE is +0.21%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, TSNLF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check UEEC's competition here
TSNLF vs GVDI Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, GVDI has a market cap of 15.8M. Regarding current trading prices, TSNLF is priced at $5.29, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas GVDI's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, TSNLF is more volatile compared to GVDI. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check GVDI's competition here
TSNLF vs OTCFF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, OTCFF has a market cap of 13.4M. Regarding current trading prices, TSNLF is priced at $5.29, while OTCFF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas OTCFF's P/E ratio is -9.64. In terms of profitability, TSNLF's ROE is +0.21%, compared to OTCFF's ROE of -7.85%. Regarding short-term risk, TSNLF is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check OTCFF's competition here
TSNLF vs TEVNF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TEVNF has a market cap of 7.5M. Regarding current trading prices, TSNLF is priced at $5.29, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TEVNF's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, TSNLF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check TEVNF's competition here
TSNLF vs IMTH Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, IMTH has a market cap of 6.4M. Regarding current trading prices, TSNLF is priced at $5.29, while IMTH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas IMTH's P/E ratio is -0.32. In terms of profitability, TSNLF's ROE is +0.21%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, TSNLF is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check IMTH's competition here
TSNLF vs RSCF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, RSCF has a market cap of 5.3M. Regarding current trading prices, TSNLF is priced at $5.29, while RSCF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas RSCF's P/E ratio is -6.21. In terms of profitability, TSNLF's ROE is +0.21%, compared to RSCF's ROE of +0.08%. Regarding short-term risk, TSNLF is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check RSCF's competition here
TSNLF vs BLMHF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, TSNLF is priced at $5.29, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, TSNLF's ROE is +0.21%, compared to BLMHF's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check BLMHF's competition here
TSNLF vs PXMVF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, TSNLF is priced at $5.29, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, TSNLF's ROE is +0.21%, compared to PXMVF's ROE of N/A. Regarding short-term risk, TSNLF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check PXMVF's competition here
TSNLF vs CBSC Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CBSC has a market cap of 4.4M. Regarding current trading prices, TSNLF is priced at $5.29, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CBSC's P/E ratio is -3.90. In terms of profitability, TSNLF's ROE is +0.21%, compared to CBSC's ROE of +1.21%. Regarding short-term risk, TSNLF is more volatile compared to CBSC. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check CBSC's competition here
TSNLF vs YBGJ Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, YBGJ has a market cap of 4.3M. Regarding current trading prices, TSNLF is priced at $5.29, while YBGJ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas YBGJ's P/E ratio is -1.79. In terms of profitability, TSNLF's ROE is +0.21%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, TSNLF is more volatile compared to YBGJ. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check YBGJ's competition here
TSNLF vs MCDA Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, TSNLF is priced at $5.29, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas MCDA's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to MCDA's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check MCDA's competition here
TSNLF vs ECIA Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ECIA has a market cap of 4.2M. Regarding current trading prices, TSNLF is priced at $5.29, while ECIA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ECIA's P/E ratio is -17.50. In terms of profitability, TSNLF's ROE is +0.21%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, TSNLF is more volatile compared to ECIA. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check ECIA's competition here
TSNLF vs TUTH Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, TUTH has a market cap of 3.6M. Regarding current trading prices, TSNLF is priced at $5.29, while TUTH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas TUTH's P/E ratio is -1.53. In terms of profitability, TSNLF's ROE is +0.21%, compared to TUTH's ROE of +0.31%. Regarding short-term risk, TSNLF is more volatile compared to TUTH. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check TUTH's competition here
TSNLF vs NSTGQ Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, TSNLF is priced at $5.29, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, TSNLF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check NSTGQ's competition here
TSNLF vs OJSY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, TSNLF is priced at $5.29, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas OJSY's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to OJSY's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check OJSY's competition here
TSNLF vs PDMI Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, TSNLF is priced at $5.29, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas PDMI's P/E ratio is -0.01. In terms of profitability, TSNLF's ROE is +0.21%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, TSNLF is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check PDMI's competition here
TSNLF vs REMI Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, REMI has a market cap of 200K. Regarding current trading prices, TSNLF is priced at $5.29, while REMI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas REMI's P/E ratio is -1.00. In terms of profitability, TSNLF's ROE is +0.21%, compared to REMI's ROE of -0.08%. Regarding short-term risk, TSNLF is more volatile compared to REMI. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check REMI's competition here
TSNLF vs WHSI Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, TSNLF is priced at $5.29, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas WHSI's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, TSNLF is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check WHSI's competition here
TSNLF vs BLFE Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, TSNLF is priced at $5.29, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas BLFE's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, TSNLF is more volatile compared to BLFE. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check BLFE's competition here
TSNLF vs QTXB Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, TSNLF is priced at $5.29, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas QTXB's P/E ratio is -0.05. In terms of profitability, TSNLF's ROE is +0.21%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, TSNLF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check QTXB's competition here
TSNLF vs CEOS Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, CEOS has a market cap of 86.2K. Regarding current trading prices, TSNLF is priced at $5.29, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas CEOS's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, TSNLF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check CEOS's competition here
TSNLF vs SDCCQ Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SDCCQ has a market cap of 40.3K. Regarding current trading prices, TSNLF is priced at $5.29, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, TSNLF is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SDCCQ's competition here
TSNLF vs GMVDF Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, TSNLF is priced at $5.29, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas GMVDF's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, TSNLF is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check GMVDF's competition here
TSNLF vs ASFX Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ASFX has a market cap of 17.5K. Regarding current trading prices, TSNLF is priced at $5.29, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ASFX's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, TSNLF is more volatile compared to ASFX. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check ASFX's competition here
TSNLF vs INND Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, INND has a market cap of 10.7K. Regarding current trading prices, TSNLF is priced at $5.29, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas INND's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to INND's ROE of +0.32%. Regarding short-term risk, TSNLF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check INND's competition here
TSNLF vs MDIT Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, MDIT has a market cap of 8.6K. Regarding current trading prices, TSNLF is priced at $5.29, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas MDIT's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, TSNLF is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check MDIT's competition here
TSNLF vs LANZ Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, LANZ has a market cap of 4.2K. Regarding current trading prices, TSNLF is priced at $5.29, while LANZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas LANZ's P/E ratio is 0.15. In terms of profitability, TSNLF's ROE is +0.21%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, TSNLF is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check LANZ's competition here
TSNLF vs DGEN Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, TSNLF is priced at $5.29, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas DGEN's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, TSNLF is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check DGEN's competition here
TSNLF vs SVSO Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, TSNLF is priced at $5.29, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SVSO's P/E ratio is -0.01. In terms of profitability, TSNLF's ROE is +0.21%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, TSNLF is more volatile compared to SVSO. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SVSO's competition here
TSNLF vs LFPI Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, LFPI has a market cap of 2K. Regarding current trading prices, TSNLF is priced at $5.29, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas LFPI's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, TSNLF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check LFPI's competition here
TSNLF vs SEYE Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, TSNLF is priced at $5.29, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SEYE's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to SEYE's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SEYE's competition here
TSNLF vs BGMD Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, TSNLF is priced at $5.29, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas BGMD's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, TSNLF is less volatile compared to BGMD. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check BGMD's competition here
TSNLF vs ADLI Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, TSNLF is priced at $5.29, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas ADLI's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, TSNLF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check ADLI's competition here
TSNLF vs VSMD Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, VSMD has a market cap of 801. Regarding current trading prices, TSNLF is priced at $5.29, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas VSMD's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, TSNLF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for TSNLF.Check VSMD's competition here
TSNLF vs HRAL Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, HRAL has a market cap of 396. Regarding current trading prices, TSNLF is priced at $5.29, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas HRAL's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, TSNLF is more volatile compared to HRAL. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check HRAL's competition here
TSNLF vs MICRD Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, MICRD has a market cap of 317. Regarding current trading prices, TSNLF is priced at $5.29, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas MICRD's P/E ratio is -0.00. In terms of profitability, TSNLF's ROE is +0.21%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, TSNLF is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check MICRD's competition here
TSNLF vs RGBOQ Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, TSNLF is priced at $5.29, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, TSNLF's ROE is +0.21%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check RGBOQ's competition here
TSNLF vs SECI Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, SECI has a market cap of 31. Regarding current trading prices, TSNLF is priced at $5.29, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas SECI's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to SECI's ROE of -0.00%. Regarding short-term risk, TSNLF is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check SECI's competition here
TSNLF vs VTEQ Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, TSNLF is priced at $5.29, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, TSNLF's ROE is +0.21%, compared to VTEQ's ROE of N/A. Regarding short-term risk, TSNLF is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check VTEQ's competition here
TSNLF vs OCPNY Comparison August 2025
TSNLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSNLF stands at 252.4M. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, TSNLF is priced at $5.29, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSNLF currently has a P/E ratio of 33.06, whereas OCPNY's P/E ratio is N/A. In terms of profitability, TSNLF's ROE is +0.21%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, TSNLF is more volatile compared to OCPNY. This indicates potentially higher risk in terms of short-term price fluctuations for TSNLF.Check OCPNY's competition here